Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Leo Pharma sets out its social media principles

Also expands its use of Twitter with two newaccounts

Leo Pharma corporate Twitter account 

Leo Pharma this month launched two new Twitter accounts to continue efforts that include publishing its social media principles. 

These state the company's desire to share information but, as would be expected given European marketing codes, won't see it "discuss or provide diagnosis of a skin condition". 

"Due to regulations, we cannot discuss pharmaceutical products. All content must be factual and non-promotional," the social media principles state.  Unsurprisingly too, the company plans to verify any external websites and links before it shares them.

The principles go on to explain that the company plans to be social in its use if social media (something that pharma often struggles with): "We will endeavour to respond to @ mentions and/or replies and ensure that any factually incorrect information shared is corrected as soon as possible.

"As a pharmaceutical company, Leo Pharma is not in a position to diagnose a skin condition or provide advice on how they should be managed, including recommending any treatments." 

Nevertheless, the company, which earlier this year submitted an aerosol foam treatment for plaque psoriasis for US approval, does want to have a dialogue on skin issues.

Adding to the @LeoHealthySkin Twitter account it started last September, Leo this month started tweeting from its new corporate @LeoPharmaCh account and the psoriasis-focused @LeoPharmaCh_pso.

26th March 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics